Enhanced-potency polio vaccine nears licensing; policy to be studied.
Marwick
C
C
D000914:Antibodies, Viral / Q000096:biosynthesis; D006801:Humans; D007115:Immunization Schedule; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage / Q000276:immunology*; D014613:Vaccines, Attenuated
D000914:Antibodies, Viral; D011054:Poliovirus Vaccine, Inactivated; D014613:Vaccines, Attenuated